HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 28, 19310-19319, July 14, 2006

This Article Full Text Full Text (PDF) All Versions of this Article: 281/28/19310    most recent M603225200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Funes, M. Articles by Sweeney, C. Search for Related Content PubMed PubMed Citation Articles by Funes, M. Articles by Sweeney, C. Social Bookmarking                      What's this?

The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3^*

Melanie Funes¹, Jamie K. Miller, Cary Lai, Kermit L. Carraway, III², and Colleen Sweeney

From the University of California-Davis Cancer Center, Sacramento, California 95817 and the Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037

Mucins provide a protective barrier for epithelial surfaces, and their overexpression in tumors has been implicated in malignancy. We have previously demonstrated that Muc4, a transmembrane mucin that promotes tumor growth and metastasis, physically interacts with the ErbB2 receptor tyrosine kinase and augments receptor tyrosine phosphorylation in response to the neuregulin-1 (NRG1) growth factor. In the present study we demonstrate that Muc4 expression in A375 human melanoma cells, as well as MCF7 and T47D human breast cancer cells, enhances NRG1 signaling through the phosphatidylinositol 3-kinase pathway. In examining the mechanism underlying Muc4-potetiated ErbB2 signaling, we found that Muc4 expression markedly augments NRG1 binding to A375 cells without altering the total quantity of receptors expressed by the cells. Cell-surface protein biotinylation experiments and immunofluorescence studies suggest that Muc4 induces the relocalization of the ErbB2 and ErbB3 receptors from intracellular compartments to the plasma membrane. Moreover, Muc4 interferes with the accumulation of surface receptors within internal compartments following NRG1 treatment by suppressing the efficiency of receptor internalization. These observations suggest that transmembrane mucins can modulate receptor tyrosine kinase signaling by influencing receptor localization and trafficking and contribute to our understanding of the mechanisms by which mucins contribute to tumor growth and progression.

Received for publication, April 5, 2006 , and in revised form, May 9, 2006.

^* This work was supported in part by California Breast Cancer Research Program Grant 7KB-0085 (to C .S.) and National Institutes of Health Grant GM068994 (to K. L. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Supported by a California Breast Cancer Research Program supplemental award (Grant 7KB-0085S).

² To whom correspondence should be addressed: University of California-Davis Cancer Center, Research Bldg. III, Rm. 1400, 4645 2nd Ave., Sacramento, CA 95817. Tel.: 916-734-0726; Fax: 916-734-0190; E-mail: klcarraway{at}ucdavis.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. C. Workman, C. Sweeney, and K. L. Carraway III The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms Cancer Res., April 1, 2009; 69(7): 2845 - 2852. [Abstract] [Full Text] [PDF]

				J. K. Miller, D. L. Shattuck, E. Q. Ingalla, L. Yen, A. D. Borowsky, L. J.T. Young, R. D. Cardiff, K. L. Carraway III, and C. Sweeney Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer Cancer Res., October 15, 2008; 68(20): 8286 - 8294. [Abstract] [Full Text] [PDF]

				E. H. Budi, L. B. Patterson, and D. M. Parichy Embryonic requirements for ErbB signaling in neural crest development and adult pigment pattern formation Development, August 1, 2008; 135(15): 2603 - 2614. [Abstract] [Full Text] [PDF]

				P. Chaturvedi, A. P. Singh, and S. K. Batra Structure, evolution, and biology of the MUC4 mucin FASEB J, April 1, 2008; 22(4): 966 - 981. [Abstract] [Full Text] [PDF]

				D. L. Shattuck, J. K. Miller, K. L. Carraway III, and C. Sweeney Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells Cancer Res., March 1, 2008; 68(5): 1471 - 1477. [Abstract] [Full Text] [PDF]

				C. A. C. Carraway and K. L. Carraway Sequestration and Segregation of Receptor Kinases in Epithelial Cells: Implications for ErbB2 Oncogenesis Sci. Signal., April 10, 2007; 2007(381): re3 - re3. [Abstract] [Full Text] [PDF]

				Z. Cao, X. Wu, L. Yen, C. Sweeney, and K. L. Carraway III Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1 Mol. Cell. Biol., March 15, 2007; 27(6): 2180 - 2188. [Abstract] [Full Text] [PDF]

				A. P. Singh, P. Chaturvedi, and S. K. Batra Emerging Roles of MUC4 in Cancer: A Novel Target for Diagnosis and Therapy Cancer Res., January 15, 2007; 67(2): 433 - 436. [Abstract] [Full Text] [PDF]

				E Tian and K. G. T. Hagen A UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase Is Required for Epithelial Tube Formation J. Biol. Chem., January 5, 2007; 282(1): 606 - 614. [Abstract] [Full Text] [PDF]